- Home
- BDTX vs ANIX Comparison
BDTX vs ANIX Comparison
Compare BDTX & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDTX | ANIX |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 104.0M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BDTX | ANIX |
|---|---|---|
| Price | $2.16 | $2.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $10.20 | $9.00 |
| AVG Volume (30 Days) | ★ 607.9K | 83.0K |
| Earning Date | 03-16-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | 12.82 |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | ★ $210,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.35 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $2.33 |
| 52 Week High | $4.94 | $5.46 |
Technical Indicators
Market Signals| Indicator | BDTX | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 43.75 | 33.42 |
| Support Level | $1.93 | N/A |
| Resistance Level | $2.86 | $3.10 |
| Average True Range (ATR) | 0.14 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 38.39 | 14.29 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.